文献速递临床试验与 GCP流行病学与生物统计

布基纳法索农村地区孕期和哺乳期强化平衡能量蛋白补充与婴儿生长:一项2×2析因个体随机对照试验

Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial.
PubMed 文献 · PLoS Med · 2023-02-06

在布基纳法索农村开展的2×2析因个体随机对照试验(MISAME-III)纳入1,897名孕周<21周的孕妇,评估孕期和哺乳期每日强化平衡能量蛋白(BEP)补充对婴儿生长的影响。孕期BEP补充使6月龄身长别年龄Z评分(LAZ)显著提高0.11 SD(95%CI 0.01至0.21,p=0.032),生长迟缓率降低3.18个百分点(95%CI -5.86至-0.51,p=0.020);产后BEP补充对6月龄LAZ或生长迟缓无统计学显著影响,但 modestly 改善产后前12个月每月LAZ增量(0.01 z-score/月,95%CI 0.00至0.02,p=0.030)。

要点

  • 孕期强化BEP补充使6月龄LAZ提高0.11 SD,生长迟缓率降低3.18个百分点。
  • 产后强化BEP补充对6月龄LAZ或生长迟缓无统计学显著影响。
  • 产后BEP补充使前12个月每月LAZ增量提高0.01 z-score/月。

核心结论

  • 孕期BEP补充对出生体格的有益影响在婴儿期以线性生长形式得以维持。
  • 哺乳期母亲BEP补充可能使婴儿期后半段线性生长略好。
  • 孕期BEP补充可有助于降低中低收入国家儿童生长迟缓的高负担。

研究设计与样本

  • 在布基纳法索Houndé区Hauts-Bassins地区6个卫生中心服务区实施的2×2析因个体随机对照试验(MISAME-III)。
  • 2019年10月至2020年12月纳入1,897名15至40岁、孕周<21周的孕妇。
  • 孕妇随机接受产前强化BEP补充加铁叶酸(IFA)片(干预)或单独IFA(对照),同时随机接受产后前6个月强化BEP补充加产后前6周IFA(干预)或产后6周单独IFA(对照)。
  • 补充剂由培训过的村级项目工作人员在每日家访中直接观察下提供。

主要发现

  • 孕期BEP补充组6月龄LAZ较对照组高0.11 SD(95%CI 0.01至0.21,p=0.032)。
  • 孕期BEP补充组6月龄生长迟缓率较对照组低3.18个百分点(95%CI -5.86至-0.51,p=0.020)。
  • 产后BEP补充对6月龄LAZ或生长迟缓无统计学显著影响。
  • 产后BEP补充组产后前12个月每月LAZ增量较对照组高0.01 z-score/月(95%CI 0.00至0.02,p=0.030)。
  • 孕期BEP干预组6月龄低体重率呈下降趋势(-2.74个百分点,95%CI -5.65至1.17,p=0.065),其余次要结局无显著影响。

临床怎么用

  • 原文结论指出孕期BEP补充可有助于降低中低收入国家儿童生长迟缓的高负担。
  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal nutrition is crucial during the critical period of the first 1,000 days from conception to 2 years after birth. Prenatal and postnatal supplementation of mothers with multimicronutrient-fortified balanced energy-protein (BEP) supplements is a potential nutritional intervention. However, evidence on the long-term effects of BEP supplementation on child growth is inconsistent. We evaluated the efficacy of daily fortified BEP supplementation during pregnancy and lactation on infant growth in rural Burkina Faso. METHODS AND FINDINGS: A 2 × 2 factorial individually randomized controlled trial (MISAME-III) was implemented in 6 health center catchment areas in Houndé district under the Hauts-Bassins region. From October 2019 to December 2020, 1,897 pregnant women aged 15 to 40 years with gestational age <21 completed weeks were enrolled. Women were randomly assigned to the prenatal intervention arms receiving either fortified BEP supplements and iron-folic acid (IFA) tablets (i.e., intervention) or IFA alone (i.e., control), which is the standard of care during pregnancy. The same women were concurrently randomized to receive either of the postnatal intervention, which comprised fortified BEP supplementation during the first 6 months postpartum in combination with IFA for the first 6 weeks (i.e., intervention), or the postnatal control, which comprised IFA alone for 6 weeks postpartum (i.e., control). Supplements were provided by trained village-based project workers under direct observation during daily home visits. We previously reported the effect of prenatal BEP supplementation on birth outcomes. The primary postnatal study outcome was length-for-age z-score (LAZ) at 6 months of age. Secondary outcomes were anthropometric indices of growth (weight-for length and weight-for-age z-scores, and arm and head circumferences) and nutritional status (prevalence rates of stunting, wasting, underweight, anemia, and hemoglobin concentration) at 6 months. Additionally, the longitudinal prevalence of common childhood morbidities, incidence of wasting, number of months of exclusive breastfeeding, and trajectories of anthropometric indices from birth to 12 months were evaluated. Prenatal BEP supplementation resulted in a significantly higher LAZ (0.11 standard deviation (SD), 95% confidence interval (CI) [0.01 to 0.21], p = 0.032) and lower stunting prevalence (-3.18 percentage points (pp), 95% CI [-5.86 to -0.51], p = 0.020) at 6 months of age, whereas the postnatal BEP supplementation did not have statistically significant effects on LAZ or stunting at 6 months. On the other hand, postnatal BEP supplementation did modestly improve the rate of monthly LAZ increment during the first 12 months postpartum (0.01 z-score/month, 95% CI [0.00 to 0.02], p = 0.030), whereas no differences in growth trajectories were detected between the prenatal study arms. Furthermore, except for the trend towards a lower prevalence of underweight found for the prenatal BEP intervention at 6 months (-2.74 pp, 95% CI [-5.65 to 1.17], p = 0.065), no other secondary outcome was significantly affected by the pre- or postnatal BEP supplementation. CONCLUSIONS: This study provides evidence that the benefits obtained from prenatal BEP supplementation on size at birth are sustained during infancy in terms of linear growth. Maternal BEP supplementation during lactation may lead to a slightly better linear growth towards the second half of infancy. These findings suggest that BEP supplementation during pregnancy can contribute to the efforts to reduce the high burden of child growth faltering in low- and middle-income countries. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03533712.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Argaw A, de Kok B, Toe LC, et al. Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial. PLoS Med. 2023. PMID: 36745684. doi:10.1371/journal.pmed.1004186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。